← Leaderboards
Miao Sun
Versapeutics Inc
$7,005,930
Attributed
$7,005,930
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,005,930 · 6
By mechanism
R44$5,266,509 · 2
R43$1,739,421 · 4
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCaliforniaSmall Business Innovation Research GrantUniversitiesLaboratoriesNovel TherapeuticsReceptorSerumTissuesRattusAntibodiesPharmaceutical PreparationsLicensingBindingHumanized AntibodyProfessorImmunogenicityPathway InteractionsPreventMonoclonal AntibodiesBrainNeuronsDoseNonhuman Primate
Grant awards (7)
Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatment$1,455,927
R44 · FY2025 · NS · contact PI
Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatment$1,430,030
R44 · FY2024 · NS · contact PI
Toxicology and Efficacy Studies of Intrathecal VersaMab-101 for spinal cord injury treatment$2,380,552
R44 · FY2023 · NS · contact PI
Developing therapeutic antibodies for Alzheimer's disease$489,628
R43 · FY2023 · AG · contact PI
Developing therapeutic antibodies for Alzheimer's disease$498,534
R43 · FY2022 · AG · contact PI
Pharmacokinetics and efficacy of intrathecal VersaMab-101 delivery foracute spinal cord injury$495,137
R43 · FY2022 · NS · contact PI
Preclinical Development of VERSAMAB-101 for Spinal Cord Injury$256,122
R43 · FY2021 · NS · contact PI